U-IMD: the first Unified European registry for inherited metabolic diseases

[1]  M. Verbeek,et al.  Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies , 2020, Orphanet Journal of Rare Diseases.

[2]  Mitsuhiro Kato,et al.  AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients , 2020, Journal of inherited metabolic disease.

[3]  V. Rubio,et al.  Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision , 2019, Journal of inherited metabolic disease.

[4]  M. Baumgartner,et al.  Phenotype, treatment practice and outcome in the cobalamin‐dependent remethylation disorders and MTHFR deficiency: Data from the E‐HOD registry , 2019, Journal of inherited metabolic disease.

[5]  M. Baumgartner,et al.  Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry , 2018, Journal of Inherited Metabolic Disease.

[6]  G. Arnold.  Inborn errors of metabolism in the 21st century: past to present. , 2018, Annals of translational medicine.

[7]  J. Oliveira,et al.  European expert consensus statement on therapeutic goals in Fabry disease. , 2018, Molecular genetics and metabolism.

[8]  C. Ferreira,et al.  A proposed nosology of inborn errors of metabolism , 2018, Genetics in Medicine.

[9]  Jasper Engel,et al.  Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients , 2018, Journal of Inherited Metabolic Disease.

[10]  I. Harting,et al.  Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity , 2017, Orphanet Journal of Rare Diseases.

[11]  M. Verbeek,et al.  Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency , 2017, Orphanet Journal of Rare Diseases.

[12]  M. Baumgartner,et al.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.

[13]  I. T. de Almeida,et al.  Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency , 2016, Journal of Inherited Metabolic Disease.

[14]  J. Friedman,et al.  The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders , 2016, Molecular genetics and metabolism reports.

[15]  H. Blom,et al.  Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders , 2016, Journal of Inherited Metabolic Disease.

[16]  M. Baumgartner,et al.  Impact of age at onset and newborn screening on outcome in organic acidurias , 2016, Journal of Inherited Metabolic Disease.

[17]  Ségolène Aymé,et al.  Rare disease policies to improve care for patients in Europe. , 2015, Biochimica et biophysica acta.

[18]  M. Baumgartner,et al.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype , 2015, Journal of Inherited Metabolic Disease.

[19]  M. Baumgartner,et al.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation , 2015, Journal of Inherited Metabolic Disease.

[20]  M. Baumgartner,et al.  Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines , 2015, Journal of Inherited Metabolic Disease.

[21]  Anita MacDonald,et al.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia , 2014, Orphanet Journal of Rare Diseases.

[22]  M. Durán,et al.  Diagnosis and management of glutaric aciduria type I – revised recommendations , 2011, Journal of Inherited Metabolic Disease.

[23]  Arrigo Schieppati,et al.  Why rare diseases are an important medical and social issue , 2008, The Lancet.

[24]  R. Steiner.  Evidence based medicine in inborn errors of metabolism: Is there any and how to find it , 2005, American journal of medical genetics. Part A.

[25]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..